Serous papillary adenocarcinomas of the ovary display heterogeneity in their response to chemotherapy

International Journal of Gynecological Cancer

Volumn 11, Issue 5, 2001, Pages 365-371

  O'Toole, S A ^a   Sheppard, B L ^a   Mcguinness, E ^a   Gleeson, N C ^a   Bonnar, J ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Chemoresistance; Chemosensitivity; Heterogeneity; MTS; Ovarian adenocarcinomas

Indexed keywords

3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM; CISPLATIN; CYTOTOXIC AGENT; PACLITAXEL; TETRAZOLIUM; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER STAGING; CELL HETEROGENEITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTADENOMA; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CISPLATIN; CYSTADENOCARCINOMA, SEROUS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; TOPOTECAN; TUMOR CELLS, CULTURED;

EID: 0034753052     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2001.01041.x     Document Type: Article

References (34)

1. The epidemiology of ovarian cancer
2. Prospective on ovarian cancer
3. Prophylactic oophorectomy for the prevention of epithelial ovarian cancer revisited
4. Surgical management of advanced ovarian cancer
5. Tumour heterogeneity and in vitro chemosensitivity testing in ovarian cancer
6. An overview of correlations between laboratory tests and clinical response
7. Winkler CF In vitro assays of chemotherapeutic sensitivity
8. Clonogenic and nonclonogenic in vitro chemosensitivity assays
9. Tumor chemosensitivity and chemoresistance assays
10. In vitro determination of drug response: A discussion of clinical applications
11. Further observations on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue
12. A feasability study of the MTT assay for chemosensitivity testing in ovarian malignancy
13. The clinical relevance of chemosensitivity testing in ovarian cancer
14. Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrial carcinomas: A comparison with cisplatin
15. Microculture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS
16. Rapid colorimetric bioassay for screening of Fusarium mycotoxins
17. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines
18. MTS interferon assay: A simplified cellular dehydrogenase assay for interferon activity using a water-soluble tetrazolium salt
19. Differential response to normal and tumor oesophageal explant cultures to radiation
20. Biological properties of 10 human ovarian carcinoma cell lines: Calibration in vitro against four platinum complexes
21. Tabular summary of pharmacokinetic parameters relevant to an in vitro drug assay
22. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: Clinical correlation for cisplatin resistance of ovarian carcinoma
23. The camptothecins
24. Topotecan effective in recurrent ovarian cancer
25. Quantitative analysis of dose effect relationships: The combined effects of multiple drugs or enzyme inhibitors
26. Chemosensitivity testing in ovarian cancer
27. Short-term in vitro chmosensitivity testing of tumors of the ovary, cervix and uterus. Measurement of DNA metabolism by 3H thymidine incorporation
28. In vitro drug testing of ovarian cancer using the human tumor colonyforming assay: Comparison of in vitro response and clinical outcome
29. High in vitro-in vivo correlation of drug response using sponge-gelsupported three-dimensional histoculture and the MTT end point
30. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
31. Use of an aqueous soluble tetrazolium formazan assay for cell growth assays in culture
32. Tumor chemosensitivity and chemoresistance assays